sulforaphane has been researched along with dactinomycin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anwar-Mohamed, A; El-Kadi, AO | 1 |
| Dashwood, RH; Dashwood, WM; Delage, B; Ho, E; Rajendran, P; Williams, DE; Wuth, B; Yu, TW | 1 |
2 other study(ies) available for sulforaphane and dactinomycin
| Article | Year |
|---|---|
Sulforaphane induces CYP1A1 mRNA, protein, and catalytic activity levels via an AhR-dependent pathway in murine hepatoma Hepa 1c1c7 and human HepG2 cells.
Topics: Animals; Brassica; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Transformation, Neoplastic; Cytochrome P-450 CYP1A1; Dactinomycin; Dose-Response Relationship, Drug; Humans; Isothiocyanates; Liver Neoplasms; Mice; Plant Extracts; Receptors, Aryl Hydrocarbon; Sulfoxides; Thiocyanates; Transcription, Genetic | 2009 |
Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly.
Topics: 14-3-3 Proteins; Acetylation; Anticarcinogenic Agents; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Colonic Neoplasms; Cycloheximide; Dactinomycin; Enzyme Activation; HCT116 Cells; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Isothiocyanates; Lysosomes; Models, Biological; NIMA-Interacting Peptidylprolyl Isomerase; Nuclear Receptor Co-Repressor 2; Peptidylprolyl Isomerase; Proteasome Inhibitors; Protein Binding; Sulfoxides; Thiocyanates | 2011 |